Abstract
Avian coccidiosis, caused by Eimeria spp., is one of the major parasitic diseases in birds. Cysteine protease is a major virulence factor in parasitic protozoa, and it may be a suitable chemotherapeutic target and vaccine candidate molecule. A 100 amino acid (aa.) partial sequence of cathepsin L, which is a cysteine protease, was reported by Katrib et al. (Ac. No. CDJ41293) (2012). A 219 aa. sequence was reported by Reid et al. (Ac. No. AFV92863) (2013). However, the open reading frame (ORF) was not reported. In this study, a full sequence of a cathepsin-L-like peptidase in Eimeria tenella (EtcatL) was obtained and its biochemical characterizations and expression profiles were analyzed across different stages of the parasite’s life cycle. Results showed that the EtcatL gene encodes a protein 470 aa. in length, with 47 and 49 % identity to Toxoplasma gondii and Eimeria acervulina. Considering the close phylogenetic relationship, TgcatL (PDB. ID 3F75) was selected for use as a template for homology modeling with quality factors of 90.9. Gelatin SDS-PAGE showed it to exert protease activity at ≈38 and ≈26 kDa. Further analysis showed the kinetic parameters of the recombinant peptidase to be K m = 8.9 μM and V max = 5.7 RFU/s μM at pH 5.5 containing 10 mM dithiothreitol (DTT) in the reaction matrix, and the IC50 value of E64 was 65.32 ± 3.02 nM. The recombinant protein was active from 25 to 50 °C, with optimal activity at 42 °C. The RT-PCR and Western blot results showed it to be expressed mainly at the endogenous stages and the initial phase of the sporulation. The protective experiment showed that chickens immunized with 100 and 200 μg rEtcatL had reduction of weight loss values 48.7 and 57.9 % those of infected controls, respectively. Their reduction of lesion scores (RLS) were 25.0 and 47.2 % that of control chickens, and relative oocyst production (ROP) was 39.6 and 15.5 % that of control chickens. These results indicate that the EtcatL can be used as an effective immunogen, and further studies are needed to enhance its potential as a vaccine candidate molecule.
Similar content being viewed by others
References
Abascal F, Zardoya R, Posada D (2005) ProtTest: selection of best-fit models of protein evolution. Bioinformatics 21(9):2104–2105
Abdul Hafeez M, Akhtar M, Hussain I (2006) Protective effect of egg-propagated Eimeria tenella (local isolates) gametocytes as vaccine(s) against mixed species of coccidia in chickens. Parasitol Res 98(6):539–544
Atkinson HJ, Babbitt PC, Sajid M (2009) The global cysteine peptidase landscape in parasites. Trends Parasitol 25(12):573–581
Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, Hanada K (1982) L-trans-Epoxysuccinyl-leucylamido(4-Guanidino)butane (E-64) and its analogs as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 201(1):189–198
Dalton JP, Neill SO, Stack C, Collins P, Walshe A, Sekiya M, Doyle S, Mulcahy G, Hoyle D, Khaznadji E, Moire N, Brennan G, Mousley A, Kreshchenko N, Maule AG, Donnelly SM (2003) Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol 33(11):1173–1181
De Vendittis E, Castellano I, Cotugno R, Ruocco MR, Raimo G, Masullo M (2008) Adaptation of model proteins from cold to hot environments involves continuous and small adjustments of average parameters related to amino acid composition. J Theor Biol 250(1):156–171
Dou Z, Carruthers VB (2011) Cathepsin proteases in Toxoplasma gondii. Adv Exp Med Biol 712:49–61
Dou Z, Coppens I, Carruthers VB (2013) Non-canonical maturation of two papain-family proteases in Toxoplasma gondii. J Biol Chem 288(5):3523–3534
Engel JC, Doyle PS, Hsieh I, McKerrow JH (1998) Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection. J Exp Med 188(4):725–734
Fujishima A, Imai Y, Nomura T, Fujisawa Y, Yamamoto Y, Sugawara T (1997) The crystal structure of human cathepsin L complexed with E-64. FEBS Lett 407(1):47–50
Fuller AL, McDougald LR (1990) Reduction in cell entry of Eimeria tenella (Coccidia) sporozoites by protease inhibitors, and partial characterization of proteolytic activity associated with intact sporozoites and merozoites. J Parasitol 76(4):464–467
Hasnain S, Hirama T, Huber CP, Mason P, Mort JS (1993) Characterization of cathepsin-B specificity by site-directed mutagenesis. Importance of Glu(245) in the S2-P2 specificity for arginine and its role in transition-state stabilization. J Biol Chem 268(1):235–240
Huang R, Que XC, Hirata K, Brinen LS, Lee JH, Hansell E, Engel J, Sajid M, Reed S (2009) The cathepsin L of Toxoplasma gondii (TgCPL) and its endogenous macromolecular inhibitor, toxostatin. Mol Biochem Parasitol 164(1):86–94
Huelsenbeck JP, Ronquist F (2001) MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17(8):754–755
Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP (2001) Bayesian inference of phylogeny and its impact on evolutionary biology. Science 294(5550):2310–2314
Jean L, Grosclaude J, Labbe M, Tomley F, Pery P (2000) Differential localisation of an Eimeria tenella aspartyl proteinase during the infection process. Int J Parasitol 30(10):1099–1107
Jean L, Pery P, Dunn P, Bumstead J, Billington K, Ryan R, Tomley F (2001) Genomic organisation and developmentally regulated expression of an apicomplexan aspartyl proteinase. Gene 262(1–2):129–136
Johnson J, Reid WM (1970) Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Exp Parasitol 28(1):30–36
Katrib M, Ikin RJ, Brossier F, Robinson M, Slapetova I, Sharman PA, Walker RA, Belli SI, Tomley FM, Smith NC (2012) Stage-specific expression of protease genes in the apicomplexan parasite, Eimeria tenella. BMC Genomics 13:685–702
Kim K (2004) Role of proteases in host cell invasion by Toxoplasma gondii and other apicomplexa. Acta Trop 91(1):69–81
Kim MJ, Yamamoto D, Matsumoto K, Inoue M, Ishida T, Mizuno H, Sumiya S, Kitamura K (1992) Crystal-structure of papain-E64-c complex binding deversity of E64-c to papain S(2) and S(3) subsites. Biochem J 287:797–803
Klemba M, Goldberg DE (2002) Biological roles of proteases in parasitic protozoa. Annu Rev Biochem 71:275–305
Kozak M (1989) The scanning model for translation - an update. J Cell Biol 108(2):229–241
Larson ET, Parussini F, Huynh MH, Giebel JD, Kelley AM, Zhang L, Bogyo M, Merritt EA, Carruthers VB (2009) Toxoplasma gondii cathepsin L is the primary target of the invasion-inhibitory compound morpholinurea-leucyl-homophenyl-vinyl sulfone phenyl. J Biol Chem 284(39):26839–26850
Laurent F, Bourdieu C, Kaga M, Chilmonczyk S, Zgrzebski G, Yvore P, Pery P (1993) Cloning and characterization of an Eimeria acervulina sporozoite gene homologous to aspartyl proteinases. Mol Biochem Parasitol 62(2):303–312
Long PL, Millard BJ, Joyner LP, Norton CC (1976) A guide to laboratory techniques used in the study and diagnosis of avian coccidiosis. Folia Vet Lat 6(3):201–217
McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M (2006) Proteases in parasitic diseases. Annu Rev Pathol Mech 1(1):497–536
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19(14):1639–1662
Ndao M, Beaulieu C, Black WC, Isabel E, Vasquez-Camargo F, Nath-Chowdhury M, Masse F, Mellon C, Methot N, Nicoll-Griffith DA (2014) Reversible cysteine protease inhibitors show promise for a chagas disease cure. Antimicrob Agents Chemother 58(2):1167–1178
Parussini F, Coppens I, Shah PP, Diamond SL, Carruthers VB (2010) Cathepsin L occupies a vacuolar compartment and is a protein maturase within the endo/exocytic system of Toxoplasma gondii. Mol Microbiol 76(6):1340–1357
Rieux A, Gras S, Lecaille F, Niepceron A, Katrib M, Smith NC, Lalmanach G, Brossier F (2012) Eimeripain, a cathepsin B-like cysteine protease, expressed throughout sporulation of the apicomplexan parasite Eimeria tenella. PLOS One 7(3):e31914
Rosenthal PJ, McKerrow JH, Aikawa M, Nagasawa H, Leech JH (1988) A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest 82(5):1560–1566
Rosenthal PJ, McKerrow JH, Rasnick D, Leech JH (1989) Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. Mol Biochem Parasitol 35(2):177–183
Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779–815
Sanderson S, Pollock K, Hilley J, MELDAL M, Hilaire P, Juliano M, JULIANO L, Mottram J, Coombs G (2000) Expression and characterization of a recombinant cysteine proteinase of Leishmania mexicana. Biochem J 347:383–388
Schaeffer M, Schroeder J, Heckeroth AR, Noack S, Gassel M, Mottram JC, Selzer PM, Coombs GH (2012) Identification of lead compounds targeting the cathepsin B-like enzyme of Eimeria tenella. Antimicrob Agents Chemother 56(3):1190–1201
Schmatz DM, Crane MS, Murray PK (1984) Purification of eimeria sporozoites by DE-52 anion-exchange chromatograpy. J Protozool 31(1):181–183
Schwarz RS, Fetterer RH, Rosenberg GH, Miska KB (2010) Coccidian merozoite transcriptome analysis from Eimeria maxia in comparision to Eimeria tenella and Eimeria acervulina. J Parasitol 96(1):49–57
Selzer PM, Pingel S, Hsieh I, Ugele B, Chan VJ, Engel JC, Bogyo M, Russell DG, Sakanari JA, McKerrow JH (1999) Cysteine protease inhibitors as chemotherapy: lessons from a parasite target. Proc Natl Acad Sci U S A 96(20):11015–11022
Shenai BR, Sijwali PS, Singh A, Rosenthal PJ (2000) Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J Biol Chem 275(37):29000–29010
Shirley MW, Smith AL, Tomley FM (2005) The biology of avian Eimeria with an emphasis on their control by vaccination. Adv Parasitol 60:285–330
Teixeira C, Gomes JRB, Gomes P (2011) Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria. Curr Med Chem 18(10):1555–1572
Teo CF, Zhou XW, Bogyo M, Carruthers VB (2007) Cysteine protease inhibitors block Toxoplasma gondii microneme secretion and cell invasion. Antimicrob Agents Chemother 51(2):679–688
Thomas T, Cavicchioli R (1998) Archaeal cold-adapted proteins: structural and evolutionary analysis of the elongation factor 2 proteins from psychrophilic, mesophilic and thermophilic methanogens. FEBS Lett 439(3):281–286
Wallace AC, Laskowski RA, Thornton JM (1995) Ligplot—a program to generate schematic diagrams of protein ligand interactions. Protein Eng 8(2):127–134
Xu JH, Qin ZH, Liao YS, Xie MQ, Li AX, Cai JP (2008) Characterization and expression of an actin-depolymerizing factor from Eimeria tenella. Parasitol Res 103(2):263–270
Xu SZ, Chen T, Wang M (2006) Protective immunity enhanced by chimeric DNA prime-protein booster strategy against Eimeria tenella challenge. Avian Dis 50(4):579–585
Acknowledgments
This research was supported by the Joint Project of Natural Science Foundation of China and the Natural Science Foundation of Guangdong Province (no. U0831004 to J. P. Cai). The authors are grateful to the technical staff of our laboratory for their assistance during this study. We would also like to thank LetPub (www.letpub.com) for linguistic assistance during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Liu, R., Ma, X., Liu, A. et al. Identification and characterization of a cathepsin-L-like peptidase in Eimeria tenella . Parasitol Res 113, 4335–4348 (2014). https://doi.org/10.1007/s00436-014-4107-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-014-4107-2